4.0 Article

Executive dysfunction in Alzheimer disease

Journal

ARCHIVES OF NEUROLOGY
Volume 61, Issue 4, Pages 556-560

Publisher

AMER MEDICAL ASSOC
DOI: 10.1001/archneur.61.4.556

Keywords

-

Funding

  1. NIA NIH HHS [AG 16570, P50 AG005131, 1-U01 AG-10483, P50 AG016570, U01 AG010483] Funding Source: Medline

Ask authors/readers for more resources

Background: Executive dysfunction (EDF) is common in Alzheimer disease (AD); however, its relationship to other symptoms is difficult to assess in patients with AD. Objectives: To determine the prevalence of EDF and study its relationship to cognitive, functional, and neuropsychiatric symptoms in patients with AD. Design, Setting, and Patients: A retrospective analysis of data from participants in the English Instruments Protocol of the Alzheimer's Disease Cooperative Study. Subjects were drawn from a sample of patients evaluated at tertiary referral centers. Results: A total of 64% of AD patients were classified as having EDF. Patients with EDF performed worse on tests of cognition (P<.001), dementia severity (P<.001), and activities of daily living (P=.01) and had more frequent symptoms of psychosis (P=.03) with greater emergence during the 12-month interval (P=.03) compared with patients with normal executive function. Less than 30% of the variance in executive function performance was explained by cognitive measures. Conclusion: These findings support the assessment of executive function in persons with AD and the importance of frontal lobe dysfunction in AD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available